Monitoring dynamic cytotoxic chemotherapy response in castration-resistant prostate cancer using plasma cell-free DNA (cfDNA)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Monitoring dynamic cytotoxic chemotherapy response in castration-resistant prostate cancer using plasma cell-free DNA (cfDNA) ; volume:12 ; number:1 ; day:15 ; month:5 ; year:2019 ; pages:1-7 ; date:12.2019
BMC Research Notes / Biomed Central; 12, Heft 1 (15.5.2019), 1-7, 12.2019
- Urheber
-
Patsch, Katherin
Matasci, Naim
Soundararajan, Anjana
Diaz, Patricia
Agus, David B.
Ruderman, Daniel
Gross, Mitchell E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13104-019-4312-2
- URN
-
urn:nbn:de:101:1-2019112821320223713532
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Patsch, Katherin
- Matasci, Naim
- Soundararajan, Anjana
- Diaz, Patricia
- Agus, David B.
- Ruderman, Daniel
- Gross, Mitchell E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer
Identification of DNA damage response-related genes as biomarkers for castration-resistant prostate cancer
Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage
Evolving Personalized Therapy for Castration-Resistant Prostate Cancer
Targeting molecular resistance in castration-resistant prostate cancer
Osteoclasts directly influence castration-resistant prostate cancer cells
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Towards systematic nomenclature for cell-free DNA
Effect of simvastatin on castration-resistant prostate cancer cells
Ureter metastatic castration-resistant prostate cancer: a case report
Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer
Identification of DNA damage response-related genes as biomarkers for castration-resistant prostate cancer
Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage
Evolving Personalized Therapy for Castration-Resistant Prostate Cancer
Targeting molecular resistance in castration-resistant prostate cancer
Osteoclasts directly influence castration-resistant prostate cancer cells
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Towards systematic nomenclature for cell-free DNA
Effect of simvastatin on castration-resistant prostate cancer cells
Ureter metastatic castration-resistant prostate cancer: a case report
Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer
Identification of DNA damage response-related genes as biomarkers for castration-resistant prostate cancer
Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage
Evolving Personalized Therapy for Castration-Resistant Prostate Cancer
Targeting molecular resistance in castration-resistant prostate cancer
Osteoclasts directly influence castration-resistant prostate cancer cells
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Towards systematic nomenclature for cell-free DNA
Effect of simvastatin on castration-resistant prostate cancer cells
Ureter metastatic castration-resistant prostate cancer: a case report